Incannex (IXHL) Healthcare announces the appointment of Douglas Kirsch, M.D., FAAN, FAASM to its IHL-42X Obstructive Sleep Apnea Clinical Advisory Board, CAB.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IXHL:
- Incannex Achieves Milestone in Sleep Apnea Drug Trial
- Incannex achieves milestone with database lock for RePOSE Phase 2 trial
- Incannex Healthcare Announces Psychedelic Therapies Joint Venture
- Incannex forms joint venture with Mind Medicine Australia
- Incannex Healthcare Transfers Listing to Nasdaq Capital Market